诚信认证：
工商注册信息已核实！
快速导航
产品分类
微信二维码
Minisite
QQ号咨询
G蛋白偶联受体&G蛋白
MBX-2982
| 品牌 | 厂商性质 | 产地 | 货期 |
|---|---|---|---|
| 阿拉丁 | 生产商 | 上海 | 现货 |
产品参数
| 货号 | CAS号 | 操作 |
|---|---|---|
| M127623-10mg | 1037792-44-1 | 询价 |
| M127623-25mg | 1037792-44-1 | 询价 |
| M127623-50mg | 1037792-44-1 | 询价 |
| M127623-5mg | 1037792-44-1 | 询价 |
产品介绍
- 分子式 C22H24N8OS
- 分子量448.54
属性
| 溶解性 | DMSO |
| 存贮条件 | 储存温度-20°C |
描述
| 产品介绍 |
MBX-2982是口服活性GPR119选择性激动剂。 |
| 生化机理 | MBX-2982 is a potential first-in-class treatment for type 2 diabetes that targets G protein-coupled receptor 119 (GPR119), a receptor that interacts with bioactive lipids known to stimulate glucose-dependent insulin secretion. Preclinical data indicate that MBX-2982 is a potent selective orally-active GPR119 agonist that functions through a unique dual mechanism of action. First, it acts directly on the beta cell to increase insulin secretion. In addition, MBX-2982 stimulates release of the incretin GLP-1 from the gut. This dual action is unique and may offer improved glucose homeostasis over existing diabetes therapies, with potential for weight loss and improved islet health. |
| 别名 | MBX 2982;MBX2982；5-乙基-2-[4-[4-[[[4-(1H-四氮唑-1-基)苯基]氧基]甲基]噻唑-2-基]哌啶-1-基]嘧啶;MBX 2982;MBX2982；5-Ethyl-2-[4-[4-[[[4-(1H-tetrazol-1-yl)phenyl]oxy]methyl]thiazol-2-yl]piperidin-1-yl]pyrimidine |
MBX-2982信息由上海阿拉丁生化科技股份有限公司为您提供，如您想了解更多关于MBX-2982报价、型号、参数等信息，欢迎来电或留言咨询。
注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途